Related Experiment Videos
HLA antigens in patients with giant cell arteritis, compared with two control groups of different ages
Insights
This study found no significant differences in Human Leukocyte Antigen (HLA) antigen prevalence in patients with Giant cell arteritis (GCA) compared to healthy controls. HLA antigen frequencies also did not vary between different GCA clinical forms or age groups.
Area of Science:
- Immunogenetics
- Rheumatology
- Vasculitis Research
Background:
- Giant cell arteritis (GCA) is a systemic vasculitis primarily affecting large and medium arteries.
- The role of Human Leukocyte Antigen (HLA) genes in GCA pathogenesis remains an area of investigation.
- Previous studies have suggested potential associations between specific HLA antigens and GCA, but findings have been inconsistent.
Purpose of the Study:
- To investigate the prevalence of 39 HLA antigens (Series A, B, and C) in patients diagnosed with Giant cell arteritis.
- To compare HLA antigen frequencies in GCA patients with those in age-matched healthy control groups.
- To explore potential associations between HLA antigen distribution and clinical manifestations or age in GCA.
Main Methods:
- Determined the prevalence of 39 HLA antigens (A, B, C series) in a cohort of 63 patients with Giant cell arteritis.
- Utilized temporal artery biopsy in 44 patients and clinical criteria in 19 patients for diagnosis confirmation.
- Compared antigen prevalence data with two distinct age-stratified control groups.
Main Results:
- No statistically significant increase in the prevalence of the studied HLA antigens was observed in Giant cell arteritis patients compared to control groups.
- Analysis revealed no significant differences in HLA antigen prevalence among patients presenting with different clinical forms of GCA.
- HLA antigen frequencies did not differ between younger and older healthy individuals in the control cohorts.
Conclusions:
- The study did not identify a significant association between the investigated HLA antigens (A, B, C series) and the susceptibility to Giant cell arteritis.
- Clinical heterogeneity of GCA does not appear to be linked to variations in the prevalence of these specific HLA antigens.
- Findings suggest that HLA antigens A, B, and C may not be major genetic determinants for Giant cell arteritis in the studied population.
Abstract:
The prevalence of 39 HLA antigens of series A, B and C was determined in 63 patients with Giant cell arteritis. In 44 patients the diagnosis was established by means of temporal artery biopsy and in 19 it was based on clinical criteria. The prevalence of the antigens was compared with that in two control groups of different ages. No significantly increased antigen prevalence was seen in our patients, as compared with controls. There were no differences in the prevalence of HLA antigens between groups of patients with different clinical forms of GCA. Nor was any difference in the prevalence of HLA antigens found between younger and older healthy individuals.